Back
ProShares Ultra Nasdaq Biotechnology Vs. Direxion Daily Real Estate Bull 3X ETF Industry Stock Comparison
Sell
47
BIB
ProShares Ultra Nasdaq Biotechnology
Last Price:
64.10
Seasonality Move:
14.04%
Buy
61
DRN
Direxion Daily Real Estate Bull 3X ETF
Last Price:
11.41
Seasonality Move:
14.12%
Sell
47
ProShares Ultra Nasdaq Biotechnology (BIB)
is a Sell
Is ProShares Ultra Nasdaq Biotechnology a Buy, Sell or Hold?
- The current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $63.13. The Score for BIB is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- BIB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Direxion Daily Real Estate Bull 3X ETF (DRN)
is a Buy
Is Direxion Daily Real Estate Bull 3X ETF a Buy, Sell or Hold?
- The current Direxion Daily Real Estate Bull 3X ETF [DRN] share price is $12.41. The Score for DRN is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- DRN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BIB Stock Price Chart
What is ProShares Ultra Nasdaq Biotechnology's stock price today?
-
The ProShares Ultra Nasdaq Biotechnology share price today is $63.13
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BIB is experiencing buying pressure, which is a positive indicator for future bullish movement.
DRN Stock Price Chart
What is Direxion Daily Real Estate Bull 3X ETF's stock price today?
-
The Direxion Daily Real Estate Bull 3X ETF share price today is $12.41
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DRN is experiencing buying pressure, which is a positive indicator for future bullish movement.
BIB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.5 | Sell |
| Relative Strength Index (14 RSI): | 50.93 | Buy |
| Chaikin Money Flow: | 4575 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (61.27 - 64.09) | Buy |
| Bollinger Bands (100): | (60.57 - 66.53) | Sell |
DRN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.15 | Sell |
| Relative Strength Index (14 RSI): | 48.5 | Sell |
| Chaikin Money Flow: | 602195 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.07 - 12.99) | Sell |
| Bollinger Bands (100): | (9.77 - 13.05) | Buy |
BIB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 62.08 | Buy |
| 20-day SMA: | 62.91 | Buy |
| 50-day SMA: | 63.97 | Sell |
| 200-day SMA: | 59.8 | Buy |
| 8-day EMA: | 62.24 | Buy |
| 20-day EMA: | 62.69 | Buy |
| 50-day EMA: | 63.25 | Sell |
| 200-day EMA: | 60.25 | Buy |
DRN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.31 | Buy |
| 20-day SMA: | 12.55 | Sell |
| 50-day SMA: | 12.79 | Sell |
| 200-day SMA: | 10.1 | Buy |
| 8-day EMA: | 12.28 | Buy |
| 20-day EMA: | 12.5 | Sell |
| 50-day EMA: | 12.36 | Buy |
| 200-day EMA: | 10.72 | Buy |
ProShares Ultra Nasdaq Biotechnology Earnings Growth & BIB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Direxion Daily Real Estate Bull 3X ETF Earnings Growth & DRN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ProShares Ultra Nasdaq Biotechnology Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Direxion Daily Real Estate Bull 3X ETF Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||